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Introduction: Minor salivary gland neoplasms of epithelial origin are rare in children and adolescents and most are
not well documented, except for a few small series and case reports. This study represents a retrospective clinical
analysis of nine cases of benign epithelial salivary gland neoplasms accessioned over a 35-year period at the
Louisiana State University School of Dentistry and combines the data with well-documented cases from the
English-language literature.
Methods: A retrospective clinical analysis of nine cases of benign epithelial salivary gland neoplasms was
performed over a 35-year period at the Louisiana State University School of Dentistry and combined with data of
well-documented cases from the English-language literature.
Results: The nine benign salivary gland neoplasms in patients aged 19 months to 18 years accounted for 2.3% of
the Louisiana State University School of Dentistry accessioned salivary gland tumors. These nine cases comprised
eight pleomorphic adenomas and one cystadenoma. There were 40 cases in the literature, of which 34 were
pleomorphic adenomas. Combining the data for the 42 pleomorphic adenomas resulted in a mean age of 12 years
with a 2.8:1 female predilection. The hard palate and/or soft palate were the most common site (69.1%). The
average duration and size was 2.1 years and 2.4cm, respectively. Bone involvement occurred in seven cases. Wide
local excision was the treatment most often employed. Cases followed for two years or more had a recurrence rate
of 13.0%. The remaining seven neoplasms in the combined data comprised myoepithelioma, cystadenoma and
sialadenoma papilliferum.
Conclusions: A relatively long duration (2 years) of a submucosal mass in a minor salivary gland-bearing area with
or without bone involvement occurring in a child or adolescent should raise the question of a possible salivary
gland neoplasm. A pleomorphic adenoma is the most common benign salivary gland neoplasm in the first and
second decade of life. Complete surgical excision affords the best chance of preventing recurrence for pleomorphic
adenomas. The recurrence rate of pleomorphic adenomas with two or more years follow-up is 13.0%. Other types
of minor salivary gland neoplasms are exceedingly rare and therefore data is sparse, precluding any valid
conclusions.
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Only 3% to5% of all salivary gland neoplasms occur in
children and adolescents [1,2]. Two types of neoplasms
are found in the salivary glands of pediatric age group
patients: neoplasms of epithelial or parenchymal origin
and neoplasms of mesenchymal or interstitial origin. The
vast majority of the mesenchymal neoplasms occurring in
the parotid gland are vasoformative, that is, hemangiomas
[1], while the most common types of salivary gland neo-
plasms of epithelial (parenchymal) origin are pleomorphic
adenomas and mucoepidermoid carcinomas.
Most of these epithelial neoplasms are found in the
parotid gland; only a limited number of cases occurring
in the minor glands of children and adolescents have
been well-documented [2]. In fact, a review of the litera-
ture revealed only 40 well-documented cases of benign
minor salivary gland tumors in this age group [3-28].
Therefore, the purpose of this retrospective analysis was
to investigate the clinical features and biologic behavior
of a series of benign epithelial minor salivary gland neo-
plasms occurring in children and adolescents, aged 19
months to 18 years.Case presentation
Prevalence
A total of nine benign minor salivary gland neoplasms
were found in patients aged below 19 years out of a total
of 396 minor salivary gland neoplasms accessioned over
a 35-year period. This is a prevalence of 2.3% in the
Louisiana State University School of Dentistry (LSUSD)
material. The neoplasms consisted of eight pleomorphic
adenomas (PA) and one cystadenoma.Figure 1 Age distribution of patients with pleomorphic adenoma arisSummary of findings
A search of the English-language literature revealed 34
PAs [3-23], four myoepitheliomas [25-28], one cystade-
noma [7], and one sialadenoma papilliferum [24]. PAs
were found to be by far the most commonly occurring
benign lesions of minor salivary glands in this age group.
A summary of the demographics, clinical findings, treat-
ment and follow-up of the well-documented benign
minor salivary gland neoplasms in the literature, in
addition to the nine new cases from LSUSD, is shown in
Additional file 1: Tables S1 and S2, for a total of 49
cases.Pleomorphic adenomas
Data for the combined 42 PAs are in Additional file 1:
Table S1. The age range was 19 months to 18 years, with a
mean of 12 years; 35.7% of the tumors occurred in
patients 10 years of age or younger. There was a marked
peak in incidence at age 12 years and then again in the
later teenage years (Figure 1). The female-to-male ratio
was calculated to be 2.8:1. Race was not stated for 21
patients (50%); for the cases reporting race there was es-
sentially an equal distribution between black and white
patients. Of the 42 neoplasms, 29 (69.1%) occurred in the
minor salivary glands of the hard and/or soft palate, six
(14.3%) in the upper lip, four (9.5%) in the buccal mucosa,
and three (7.1%) in the tongue. Seven of the palatal neo-
plasms caused pressure erosion, a smooth depression, or
perforation of the under lying bone. One of these palatal
neoplasms perforated the palatal bone and extended into
the nasal cavity. The majority of PAs were painless, firm
submucosal masses or nodules ranging in size from 0.5cming from minor salivary glands.
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had reliable patient history reporting a 2.1 year duration
of the tumor before definitive diagnosis.
Twenty-four cases with follow-up information of at
least 2 years were treated by local surgical excision.
Follow-up ranged from 2 to 39 years (mean 9.2 years).
Recurrences were reported in three cases for a recur-
rence rate of 13.0%. The three recurrent cases were all
on the hard palate and recurred 2 years, 3 years, and
5 years after the initial surgery.
Other lesions
Data for the two cystadenomas, one sialadenoma papilli-
ferum and the four myoepitheliomas are presented in
Additional file 1: Table S2.
Discussion
We attempted to outline the clinical features and biologic
behavior of benign neoplasms arising from minor salivary
glands in children and adolescents. It is acknowledged that
there are limitations to the interpretation of data from a
retrospective study such as this. For example, the clinical
findings and other pertinent information recorded on sub-
mitted pathology request forms are unfortunately highly
variable and often lack complete information and the
same is true for reported cases.
While more pediatric cases have been reported cumu-
latively in other published salivary gland series, any cor-
relation between patient-specific details and the clinical
lesion cannot be made. The approach of our study limits
the number of accepted cases, but yields more clinically
relevant information. The patients in the LSUSD series
were only from the state of Louisiana, thus representing
patients from a single geographic area and a single insti-
tution experience. The cases accepted from the literature
review represent a more global pediatric population, in-
cluding Hispanic and Asian children, who were not
represented in our LSUSD series. Since the socioeco-
nomic status of the children was not known in our
study, the association of socioeconomic status to the in-
cidence as well as prognosis of the lesions could not be
explored.
Epithelial neoplasms originating in the minor salivary
glands account for approximately 15% of all salivary
gland neoplasms [29,30]. In the current LSUSD series,
2.3% of the benign epithelial minor salivary gland neo-
plasms occurred in patients below 19 years of age, which
is in close agreement with the series of Waldron et al.
and Kusama et al. who found an incidence of 3.1% and
4.6%, respectively [30,31].
A PA is composed of a wide spectrum of epithelial and
mesenchymal tissue derived from cells with ductal and
myoepithelial features and it is by far the most common
salivary gland neoplasm in children [1,32]. Although it iscommonly stated that neoplasms of minor salivary
glands rarely occur prior to the second decade [33], we
found that, when combining the well-documented litera-
ture cases with our LSUSD cases, 28.6% of PAs arising
from minor salivary glands in children occurred during
the first decade of life. Cumulative data assessment
revealed a female gender predilection of 2.8:1 and a pre-
dilection for the hard and/or soft palate (69.1%).
Information regarding the biologic behavior of minor
salivary gland PAs in children and adolescents is, in gen-
eral, underprovided. The risk of recurrence of PAs has
been speculated to be lower if arising from the minor
salivary glands rather than the major glands [34]. In fact,
Chau and Radden reported follow-up on 27 intra-oral
PAs in patients over a wide age range (second to eighth
decade) treated by excisional biopsy and found no recur-
rences (mean follow-up period 5.3 years), including in
two neoplasms which were incompletely excised and
two where the tumor extended to the surgical margins
[35]. Additionally, Budnick reported a PA in the upper
lip of a 17-year-old black woman which was incom-
pletely excised and had no evidence of recurrence on
3 years of follow-up [7]. The recurrence rate of PAs in
minor salivary glands of children in our study was
13.0%, which is of clinical significance. This recurrence
rate was recorded from 24 well-documented pediatric
and adolescent PAs with an average follow-up duration
of 9.2 years. The three recurrent PAs involved the hard
palate, with one causing bone resorption, one with no
bone involvement [19] and one case did not state if
there was bone involvement [3]. The assessment for pos-
sible causes of recurrence in the three cases varied. The
size of the lesion was recorded in two of the three recur-
rent cases; both were 2.0cm or less in diameter. With
regards the surgical margins of these recurrent cases,
Byars et al. [3] did not comment on the state of the sur-
gical margins, Shaaban et al. [19] reported the surgical
margins in the definitive excision were free of tumor
and, in the LSUSD case, the margins could not be defini-
tively determined as treatment consisted of tumor exci-
sion with curettage of the involved palatal bone, making
assessment difficult to evaluate with certainty.
In the cases with no recurrence, the surgical margins
were not described with any degree of certainty, making
it impossible to adequately explore margin involvement
as an absolute predictor of recurrence. However, in four
of the newly reported LSUSD cases with follow-up of
8 months, 5 years, 8 years and 24 years, the surgical
margins were free of tumor. Of those, the case that was
followed for 5 years had a focus of tumor in the capsule,
but did not recur.
A myoepithelioma is a benign tumor composed of
various proportions of plasmacytoid, spindle, epithelioid,
and clear cells that exhibit myoepithelial differentiation
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some investigators consider it to be a distinct entity,
others believe that it represents one end of the spectrum
of the PA and is therefore a variant of PA [27,36]. Re-
gardless of its specific classification, it possesses a similar
if not identical biologic behavior to a PA [36]. There are
too few cases reported to define its characteristics in the
first and second decade of life. However, based on four
cases, it does appear to possess similar clinical character-
istics and biologic behavior to a PA (Additional file 1:
Table S2).
Minor salivary gland cystadenomas are rare benign
well-circumscribed tumors composed of cystic and pap-
illary structures lined with cuboidal or columnar ductal
epithelium that appears benign on histology [30]. The
average age of incidence is 57 years; they are exceed-
ingly rare below the age of 20 years. The youngest pa-
tient reported to have a cystadenoma was 12 years old
[7]. Lastly, a sialadenoma papilliferum is a benign exo-
phytic papillary tumor arising from the salivary gland
duct. It too is rare below the age of 20 years with only
one case reported, in the upper lip of an 18-year-old
man [24].
Although minor salivary gland tumors are decidedly
uncommon in the first two decades of life, they should
be considered in the clinical differential diagnosis for
any submucosal nodule or mass in a salivary gland-
bearing area. In this study, the average duration of 16
PAs with reliable historical information was 2.1 years be-
fore definitive diagnosis. As with any benign or malig-
nant tumor, early definitive diagnosis and appropriate
treatment afford a better chance for a cure. This is espe-
cially important for minor salivary gland tumors because
a high percentage are malignant [1,2].
Conclusions
The following may be concluded from the results of this
study regarding benign epithelial (parenchymal) minor
salivary gland tumors in children and adolescents (ages
19 months to 18 years):
1. The prevalence of benign epithelial minor salivary
gland tumors in the LSUSD series was 2.3%.
2. Minor salivary gland tumors are more common in
female patients.
3. Minor salivary gland tumors have a high predilection
for the hard and/or soft palate and have been well-
documented in lesser numbers in the upper lip,
buccal mucosa, and tongue.
4. Minor salivary gland tumors involving the hard
palate may resorb underlying bone.
5. The long duration of a painless submucosal mass in a
salivary gland-bearing area does not preclude a
minor salivary gland neoplasm.6. The recurrence rate of minor salivary gland PAs in
the first two decades of life is low (13.0%) based on
this review of 24 well-documented cases with two or
more years follow-up.
7. Complete surgical excision is the most important
factor in preventing recurrence of a benign minor
salivary gland neoplasm.
8. Long-term clinical follow-up of at least 5 years and
the possibility of recurrence should be discussed with
the patient and parents when benign minor salivary
gland tumors are diagnosed in pediatric and
adolescent patients.
Methods
The archived oral pathology cases from the LSUSD Div-
ision of Oral and Maxillofacial Pathology diagnosed as
benign salivary gland tumors from January 1 1969 to
December 31 2004 were reviewed and patients aged
below 19 years with any type of intra-oral benign minor
salivary gland neoplasm were selected. The search fo-
cused on all types of benign minor salivary gland neo-
plasms in this age group. All cases consisted of
hematoxylin and eosin-stained microscopic slides and
the accompanying pathology request form. No cases
were rejected for lack of detailed clinical or treatment
information. There were no missing specimens or
reports in the LSUSD archives. All of the cases in this
study were submitted by oral and maxillofacial surgeons
in private practice in the state of Louisiana with the ex-
ception of one case, which was from the LSUSD Depart-
ment of Oral and Maxillofacial Surgery. The Louisiana
State University Health Sciences Center Institutional Re-
view Board (LSUHSC IRB) approved the research proto-
col (IRB #6450). Demographic, clinical, and treatment
information was recorded for each patient. All of the
microscopic diagnoses were made by American Board of
Oral and Maxillofacial Pathology-certified pathologists.
Additionally, the microscopic diagnosis of each case was
reviewed and verified by one of the authors (RBB), an
American Board of Oral and Maxillofacial Pathology-
certified pathologist, using the diagnostic criteria for PAs
and cystadenomas set forth by Ellis and Auclair [36]. A
search was performed of the English-language medical
and dental literature for well-documented minor salivary
gland neoplasms in the pediatric and adolescent age
group. It should be noted that, although numerous
investigators have published series of salivary gland neo-
plasms, they provide an age range only and do not cor-
relate the age of the patient to the location of the lesion
or offer other demographic and clinical information.
Some of these series did indicate that at least one patient
was in the first or second decade of life; however, we did
not include them in this study because they lacked the
adequate detail we required.
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